Juris Doctor with honors, from Hofstra University School of Law in 2011.
Editor, Law Review
Bachelor of Science in Finance from Binghamton University in 2008.
Admitted to Practice:
Gregory has provided counsel to over $1 billion in transaction volume at global scale with a strong focus on the sciences involving multi-national corporations and the federal government. Gregory’s experience includes advancing various pharmaceutical assets through laboratory, animal, formulation, manufacturing, clinical trials (Phase I - III) as well as commercialization. In addition, he provides counsel on various environmental matters including chemical contamination of water, air and real property.
Mr. Rigano is an Advisor to the Stanford University School of Medicine SPARK Translational Research Program and is pursuing a Masters of Science in Bioinformatics from Johns Hopkins. He earned his Juris Doctor, with honors, from Hofstra University Schoo of Law, where he served as an editor of the Law Review, founder of the Dispute Resolution Society and interned in the enforcement division of the Financial Industry Regulatory Authority, NYSE Euronext. He was a corporate associate at the international law firm Chadbourne & Parke LLP (now known as Norton Rose Fulbright) where he provided counsel for corporate transactions on various research, development and commercialization agreements for assets on every inhabited continent.